Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.5936
-0.0214 (-3.48%)
Dec 8, 2025, 4:00 PM EST - Market closed
Longeveron Market Cap
Longeveron has a market cap or net worth of $12.66 million as of December 8, 2025. Its market cap has decreased by -53.86% in one year.
Market Cap
12.66M
Enterprise Value
4.97M
1-Year Change
-53.86%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $12.66M, a decrease of -92.66%. That is a compound annual growth rate of -41.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 13.12M | -48.89% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | 172.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |